Aistiva Corporation, a subsidiary of Verity Corp, is a life sciences research and development company creating novel products for numerous industries. The company's patented technology influences biological processes naturally and without chemical interaction which holds promise in enhancing crop yields to providing drug-free medicine, Aistiva is providing innovative physics-based solutions to the world's largest problems. To learn more about Aistiva, please visit: www.aistiva.com.
Safe Harbor: Statements contained in this news release, other than those identifying historical facts, constitute "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934 and the Safe Harbor provisions as contained in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relating to the Company's future expectations, including but not limited to revenues and earnings, technology efficacy, strategies and plans, are subject to safe harbors protection. Actual Company results and performance may be materially different from any future results, performance, strategies, plans, or achievements that may be expressed or implied by any such forward-looking statements. The Company disclaims any obligation to update or revise any forward-looking statements.
Contact:Verity Corp Investor Relations InvestorRelations@mindspring.com360-782-4477
SOURCE Verity Corp